Please assess the completion status of the following clinical trial:

Trial Title: Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Epilepsy participants from 12 to 17 years of age with:~  * Partial seizures (with or without secondary generalized seizures)~ * Primary generalized Tonic-clonic seizures~Exclusion Criteria:~* Participants previously treated with Fycompa

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Fycompa-treated epilepsy participants (Type: None): Adolescent epilepsy participants with partial-onset seizures (with or without secondary generalized seizures) or primary generalized Tonic-clonic seizures who receive long-term treatment with Fycompa

Based on this trial design, predict the completion outcome and termination type (if applicable).